sustain 6 trial semaglutide ๐ SUSTAIN-6 (NEJM 2016) โ the safety that became a landmark., In 3,297 patients with type 2 diabetes at high CV risk, reduced:, โข 3-point MACE 26% (HR 0.74), โข Nonfatal stroke 39% Oral Semaglutide and Cardiovascular Outcomes
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 6 - Aug 11



30311-0/asset/8d082169-7782-45b8-bd5b-72e68596751e/main.assets/gr2_lrg.jpg)























